Search

Author/Creator Hwang, Larn

1. ATIM-03. ANTI-TGFß2 RNA THERAPEUTIC OT-101 INDUCES DURABLE OBJECTIVE RESPONSES IN PATIENTS WITH RECURRENT/REFRACTORY (R/R) GLIOBLASTOMA MULTIFORME (GBM, WHO GRADE 4) OR ANAPLASTIC ASTROCYTOMA (AA, WHO GRADE 3). (11th November 2019)

Authors:
Uckun, Fatih; Qazi, Sanjive; Hwang, Larn; Nam, David; Trieu, Vuong
Journal:
Neuro-oncology
Issue:
Volume 21(2019)Supplement 6
Page Start:
vi1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Preclinical and Clinical Studies on Safety of CEQ508 Bacteria Engineered to Deliver Short‐Hairpin RNA to Mediate RNA Interference Against β‐catenin in the GI Tract of Patients With Familial Adenomatous Polyposis: 297. (October 2017)

Authors:
D'Cruz, Osmond; Hwang, Larn; Fong, Annie; Ng, Kevin; Nam, David; Wang, Wen; Trieu, Vuong
Journal:
American journal of gastroenterology
Issue:
Volume 112(2017)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗